JVACX
Price
$38.07
Change
+$0.31 (+0.82%)
Updated
Jun 26 closing price
Net Assets
8.8B
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

JVACX vs RMEBX

Header iconJVACX vs RMEBX Comparison
Open Charts JVACX vs RMEBXBanner chart's image
JPMorgan Value Advantage C
Price$38.07
Change+$0.31 (+0.82%)
VolumeN/A
Net Assets8.8B
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
JVACX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JVACX vs. RMEBX commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVACX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. JVACX (8.8B). RMEBX pays higher dividends than JVACX: RMEBX (1.16) vs JVACX (0.71). JVACX was incepted earlier than RMEBX: JVACX (20 years) vs RMEBX (11 years). JVACX (1.60) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. JVACX (17.00). RMEBX has a lower initial minimum investment than JVACX: RMEBX (250) vs JVACX (1000). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. JVACX (2.05). RMEBX return over 5 years is better than : 62.71 vs. JVACX (35.87).
JVACXRMEBXJVACX / RMEBX
Total Expense Ratio1.491.07139%
Annual Report Gross Expense Ratio1.601.07150%
Fund Existence20 years11 years-
Gain YTD1.3157.31518%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets8.8B106B8%
Annual Yield % from dividends0.711.1661%
Returns for 1 year2.059.5022%
Returns for 3 years4.3625.8817%
Returns for 5 years35.8762.7157%
Returns for 10 years33.5674.5145%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp